The CD95/CD95L signaling pathway: a role in carcinogenesis

Area of Science:

• Cell Biology
• Immunology
• Molecular Biology

Background:

• Apoptosis is crucial for tissue homeostasis, immune responses, and development.
• The CD95 receptor (Fas) and its ligand (CD95L) are involved in immune regulation.
• CD95 was initially considered a tumor suppressor due to loss-of-function mutations in cancer.

Purpose of the Study:

• To review the dual role of the CD95 receptor in apoptosis and non-apoptotic signaling.
• To explore the potential involvement of CD95 in inflammation and carcinogenesis.
• To compare CD95 signaling with other Tumor Necrosis Factor Receptor (TNF-R) pathways.

Main Methods:

• Literature review and comparative analysis of signaling pathways.
• Examination of molecular mechanisms underlying CD95 signal transduction.
• Discussion of existing data on CD95's role in different pathophysiological contexts.

Main Results:

• CD95 can transmit non-apoptotic signals, promoting inflammation and potentially contributing to carcinogenesis.
• Evidence suggests CD95 utilizes distinct molecular mechanisms (NF-κB, MAPK, PI3K) for non-apoptotic signaling.
• The precise molecular switch between apoptotic and inflammatory functions of CD95 remains unclear.

Conclusions:

• The CD95 receptor exhibits context-dependent functions beyond apoptosis.
• Understanding the non-apoptotic signaling of CD95 is critical for elucidating its role in disease.
• Further research is needed to elucidate the biological functions and regulatory mechanisms of CD95-mediated non-apoptotic signals.